Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 460 results for "zydus cadila"

Cadila shares rise as FDA inspection for its Ahmedabad SEZ tablets plant closes

BRIEF-Cadila Healthcare says Zydus signs deal with MMV to deve...

Sept 30 Cadila Healthcare Ltd: * Zydus and Medicines for Malaria Venture sign agreement to develop potential new antimalarial drug * Zydus will lead development of novel compound and MMV will provide support Source text: Further ... Reuters UK, 28 minutes ago

66 images for zydus cadila

Money Today, 1 week ago
Financial Express, 1 week ago
Indian Express, 1 week ago
Silicon India, 1 week ago, 1 week ago
Pharmaceutical Technology, 1 week ago
DNA, 1 week ago
Pharma Business International, 1 week ago
Money Control, 2 weeks ago
Pharmafile, 1 week ago
Pharmaceutical Technology

Zydus and Takeda collaborates for chikungunya vaccine

Share Tweet Share Share Share Zydus Cadila and Takeda Pharmaceutical have entered into partnership to develop the first vaccine to treat chikungunya virus infection. The broad-based agreement includes early stage development ...
 EHealth Magazine1 week ago Cadila JV to develop vaccine for chikungunya  News Today1 week ago Takeda and Zydus Cadila partner to address the global threat of Chikungunya  Business Wire1 week ago Zydus Cadila and Takeda partner to develop vaccine for Chikungunya virus  Pharmaceutical Technology1 week ago
India Infoline

Zydus, Takeda partner to develop & market chikungunya vaccine

Zydus Cadila, an innovation driven global healthcare provider and Takeda Pharmaceutical Company Limited, (Takeda), announced a partnership to tackle chikungunya, an emerging infectious disease. The chikungunya virus is most often spread to people by ...
 PharmaBiz1 week ago Zydus Cadila enters into partnership with Takeda  HT Syndication1 week ago Zydus and Takeda enter into partnership to address emerging infectious diseases  India Infoline1 week ago Zydus & Takeda partner to address emerging infectious disease  Pharma Business International1 week ago

Zydus Cadila, Takeda to co-develop vaccine for chikungunya

Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly develop the vaccine right from the early-stage development to its ...
 CPhI.cn3 days ago

Pfizer launches legal action to block Xeljanz copies in India

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts to copy its rheumatoid arthritis (RA) treatment Xeljanz. The US pharma firm filed a case last month against Sun ...
 Pharmafile2 weeks ago Court battle over Zydus Cadila's breast cancer drug continues  Economic Times1 month ago Court defers decision on Roche's plea against Zydus' cancer drug  Economic Times1 month ago Now, Roche takes Zydus Cadila to court over breast cancer drug  Economic Times1 month ago
Financial Express

Zydus Recalls 14,800 Bottles Of Bromocriptine Mesylate Capsules

New Delhi : Zydus Cadila is recalling over14,800 bottles of Bromocriptine Mesylate capsules manufacturedby Cadila Healthcare on account of out of specificationresults. According to information available on the USFood and Drug Administration (FDA) ...
 NDTV2 weeks ago
VC Circle

Cadila Healthcare ends in red; acquires derma brand of Issar Pharma

The Zydus Group, an innovation-led global healthcare provider announced that it has acquired Melgain from Hyderabad based Issar Pharma.
 India Infoline1 month ago Cadila buys skin-care brand Melgain from Issar Pharma  VC Circle1 month ago Zydus acquires skin treatment lotion Melgain from Issar Pharma  Times of India1 month ago Cadila Healthcare advances on acquiring Melgain lotion from Issar Pharma  Finalaya.com1 month ago

Zydus recalls over 2lakh bottles of anti-depressant drug in US

Zydus Cadila is recalling over 2 lakh bottles of anti-depressant Venlafaxine HCL ER capsules in the US in two different strengths for failed dissolution specifications. According to information available on the United States Food and Drug ...
 Business Standard1 month ago Zydus Recalls Over Two Lakh Bottles Of Anti-Depressant Drug In US  NDTV Profit1 month ago Zydus Cadila recalls over 2lakh bottles of anti-depressant drug in US  Financial Express1 month ago Zydus recalls over 2 lakh bottles of anti-depressant drug in US  Money Control1 month ago
Business Line

Zydus inks sub-licensing agreement with MPP for hepatitis medicine

Healthcare major Zydus Cadila has entered into a non-exclusive, royalty-free agreement with Medicines Patent Pool (MPP) for the generic production of Bristol-Myers Squibbs daclatasvir, a novel direct-acting antiviral (DAA), that is proven to help cure ...
 Business Line2 months ago Cadila up 4% on sub-licensing agmt with UN health organisation  Money Control2 months ago
The Telegraph

Quartet picked to buy Teva drugs

Four Indian companies - Cipla, Aurobindo Pharma, Dr Reddy's and Zydus Cadila - are among the 11 companies to buy 79 existing and future drugs of Teva Pharmaceutical Industries. The divestment is one of the conditions set by the US Federal Trade Commission ...
 The Telegraph2 months ago Indian drugmakers among final few bidders for $1B Teva generics unit  FiercePharma1 month ago Aurobindo, Intas bid for Teva's products in Europe  VC Circle1 month ago Cipla, Aurobindo Pharma acquire products divested by Teva in US  Livemint.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less